Literature DB >> 25407128

Colchicine treatment reversibly blocks cytokinesis but not mitosis in Trypanosoma cruzi epimastigotes.

Mariana Potenza1, María Teresa Tellez-Iñón.   

Abstract

This work analyzes the effect of the alkaloid colchicine on the growth of Trypanosoma cruzi epimastigotes, using immunofluorescence microscopy and flow cytometry techniques. We found that colchicine reversibly inhibited cytokinesis but not synthesis or segregation of nuclear and kinetoplastid DNA, in a concentration-dependent manner. We showed that, once colchicine was removed from the growth medium, cytokinesis was restored but abnormal segregation of kinetoplasts and nuclei generated zoids and parasites with two nuclei and one kinetoplast, among other aberrant cells. After drug removal, we also observed a few anucleated cells carrying two kinetoplasts in a stage compatible with the end of cytokinesis. The anomalous subcellular localization of the kinetoplast and flagellum observed in treated parasites suggests that the effect of colchicine and its interaction with T. cruzi microtubules is cell cycle dependent. The crosstalk between nuclear and kinetoplastid mitosis and its incidence on flagellum growth and parasite cell division regulation are discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25407128     DOI: 10.1007/s00436-014-4227-8

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  49 in total

1.  A differential role for actin during the life cycle of Trypanosoma brucei.

Authors:  José A García-Salcedo; David Pérez-Morga; Purificación Gijón; Vincent Dilbeck; Etienne Pays; Derek P Nolan
Journal:  EMBO J       Date:  2004-02-12       Impact factor: 11.598

Review 2.  Colchicine in clinical medicine. A guide for internists.

Authors:  Giuseppe Cocco; David C C Chu; Stefano Pandolfi
Journal:  Eur J Intern Med       Date:  2010-11-05       Impact factor: 4.487

Review 3.  Colchicine for the Treatment of Acute and Recurrent Pericarditis.

Authors:  Sarah E Norrid; Carrie S Oliphant
Journal:  Ann Pharmacother       Date:  2014-05-19       Impact factor: 3.154

Review 4.  Dealing with environmental challenges: mechanisms of adaptation in Trypanosoma cruzi.

Authors:  Veronica Jimenez
Journal:  Res Microbiol       Date:  2014-02-06       Impact factor: 3.992

5.  The three-dimensional structure of the cytostome-cytopharynx complex of Trypanosoma cruzi epimastigotes.

Authors:  Carolina L Alcantara; Juliana C Vidal; Wanderley de Souza; Narcisa L Cunha-e-Silva
Journal:  J Cell Sci       Date:  2014-03-07       Impact factor: 5.285

6.  Evidence for CRK3 participation in the cell division cycle of Trypanosoma cruzi.

Authors:  María I Santori; Sebastián Laría; Eliana B Gómez; Ingrid Espinosa; Norbel Galanti; María T Téllez-Iñón
Journal:  Mol Biochem Parasitol       Date:  2002-05       Impact factor: 1.759

Review 7.  American trypanosomiasis (Chagas disease).

Authors:  Anis Rassi; Anis Rassi; Joffre Marcondes de Rezende
Journal:  Infect Dis Clin North Am       Date:  2012-06       Impact factor: 5.982

Review 8.  The structural mechanics of cell division in Trypanosoma brucei.

Authors:  Sue Vaughan; Keith Gull
Journal:  Biochem Soc Trans       Date:  2008-06       Impact factor: 5.407

Review 9.  Colchicine update: 2008.

Authors:  Robert A Terkeltaub
Journal:  Semin Arthritis Rheum       Date:  2008-10-29       Impact factor: 5.532

10.  Effect of colchicine on myocardial injury induced by Trypanosoma cruzi in experimental Chagas disease.

Authors:  Fábio Fernandes; Felix José Alvarez Ramires; Barbara Maria Ianni; Vera Maria Cury Salemi; Adriana Morgan Oliveira; Fernanda Gallinaro Pessoa; Mauro Canzian; Charles Mady
Journal:  J Card Fail       Date:  2012-08       Impact factor: 5.712

View more
  1 in total

Review 1.  Who Needs a Contractile Actomyosin Ring? The Plethora of Alternative Ways to Divide a Protozoan Parasite.

Authors:  Tansy C Hammarton
Journal:  Front Cell Infect Microbiol       Date:  2019-11-21       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.